about
Role of Peroxisome Proliferator-Activated Receptor γ in Ocular DiseasesEffects of non-supervised low intensity aerobic excise training on the microvascular endothelial function of patients with type 1 diabetes: a non-pharmacological interventional study.Systems Toxicology of Male Reproductive Development: Profiling 774 Chemicals for Molecular Targets and Adverse OutcomesPharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicine.Differential sensitivities of the vascular K(ATP) channel to various PPAR activatorsNuclear receptors and pathogenesis of pancreatic cancer.Molecular Implications of the PPARs in the Diabetic Eye.Peroxisome proliferator-activated receptor δ agonist, HPP593, prevents renal necrosis under chronic ischemia.Coordinated Activation of VEGF/VEGFR-2 and PPARδ Pathways by a Multi-Component Chinese Medicine DHI Accelerated Recovery from Peripheral Arterial Disease in Type 2 Diabetic Mice.Vascular effects of prostacyclin: does activation of PPARδ play a role?Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer.Live cell screening platform identifies PPARδ as a regulator of cardiomyocyte proliferation and cardiac repairEndothelial differentiation in multipotent cells derived from mouse and human white mature adipocytes.Inducible Conditional Vascular-Specific Overexpression of Peroxisome Proliferator-Activated Receptor Beta/Delta Leads to Rapid Cardiac HypertrophyAdvances and challenges in skeletal muscle angiogenesis.Functional Role of PPARs in Ruminants: Potential Targets for Fine-Tuning Metabolism during Growth and LactationY-27632 Increases Sensitivity of PANC-1 Cells to EGCG in Regulating Cell Proliferation and MigrationMechanisms governing the health and performance benefits of exercise.Adipose tissue angiogenesis: impact on obesity and type-2 diabetes.Loss of PPARγ in endothelial cells leads to impaired angiogenesis.Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter.Telmisartan exerts anti-tumor effects by activating peroxisome proliferator-activated receptor-γ in human lung adenocarcinoma A549 cells.Peroxisome proliferator-activated receptor (PPAR) α and δ activators induce ICAM-1 expression in quiescent non stimulated endothelial cells.PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer.SERPINA3K induces apoptosis in human colorectal cancer cells via activating the Fas/FasL/caspase-8 signaling pathway.Topically administered rhGM-CSF affects PPARβ expression in the stasis zone.A selective peroxisome proliferator-activated receptor-β/δ agonist attenuates neointimal hyperplasia after wire-mediated arterial injury.Advances in the cellular and molecular biology of angiogenesis.Treatment with a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma cruzi-Infected Mice.Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.Lipids and Diabetic Retinopathy.
P2860
Q27022548-1EF4825C-A11F-4AA1-8DF0-A9963EABE352Q27315227-E26F5387-BE08-47A6-9E55-06B0C52BF8EFQ28830901-114047B2-14E2-4AEF-8161-EF8FDB19111DQ30728815-114FADBD-844B-479D-8662-1216DAC46E44Q34044879-B8429BBC-DF7F-416C-BAF0-26C4CEB400BCQ34168476-6F4D7121-B77D-4FE0-BA9D-8E2B927BB308Q34594935-C5BECADB-002D-4646-9E21-15D1CFEBD8B5Q34731608-2D626F32-329F-4D13-BDCE-893058C05A9BQ36216091-D295C3DC-1BD9-4EE2-BB49-95C6EF5A6C22Q36287741-EF447630-A0C3-4C83-951B-4287F14FA823Q36368271-D9C96EB4-98C2-4F88-B6B6-16E62423B704Q36407101-A54B861A-EFD6-4CA0-B7D5-C6383A8C5AD4Q36470694-122255E7-E3CD-41D0-8CF3-C49AF0821726Q36693781-F36B1446-EDA5-4B3C-8F97-8D5272505FA0Q36699616-AB2E5FEB-B456-4897-A68C-0D529ABD7023Q36853537-D8FC6592-A4D6-410F-9CC9-E0B125722815Q37337818-0C26C108-F9D2-4555-825E-F4784F632C18Q37337855-BE8ECDA3-36DA-4C34-A402-19B2BD3E3F6BQ37352210-FA68A3D0-7CF5-4420-A001-F7A1A9B8B0E2Q37413074-7A835E13-2B02-4C43-8347-8CFECAE1AD25Q38799227-4E371141-414B-44EE-8400-E7340399D95DQ39017939-D2E3930C-6BAE-4AAE-A59B-EB90458947D5Q39468345-E37B171F-8829-4DF3-A6BF-02A8453EE594Q39584017-BF8E3787-6F5A-433A-8D3F-B00097BD189FQ44088705-4D71CB28-C8A1-4EFE-A056-DB25055FC574Q47132661-27C7E050-1CC4-4C07-916F-565A16042A10Q47858945-ADFAE069-508E-47BD-9AEF-15097382D9A9Q48536486-D8EAF3C2-E4AC-4D32-88A8-4976C8FF23DAQ49215894-CAA4423E-38EF-46F7-ABAD-B99549D36ACAQ52715797-954586E5-E498-4C0C-86C5-E2054070F668Q53205337-B2F7CCAB-F515-4238-9533-08C204B0DD3F
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
PPARs and angiogenesis.
@en
PPARs and angiogenesis.
@nl
type
label
PPARs and angiogenesis.
@en
PPARs and angiogenesis.
@nl
prefLabel
PPARs and angiogenesis.
@en
PPARs and angiogenesis.
@nl
P2860
P356
P1476
PPARs and angiogenesis.
@en
P2093
David Bishop-Bailey
P2860
P304
P356
10.1042/BST20110643
P577
2011-12-01T00:00:00Z